NAVCO Pharmaceuticals Inc.
Loading stock data...
Stock Performance
Price History
-
Drag to select time range
-
Market Data
Market Cap
285,347
P/E Ratio
-
52-Week High
-
52-Week Low
-
Avg Volume
-
Beta
-
Forward P/E
-
Dividend Yield
-
EV/Revenue
-
Price/Book
-
Business Overview
NAVCO Pharmaceuticals Inc. develops and commercializes supplemental and therapeutic consumer health and wellness products in the areas of antibacterial and immunity support and infectious disease prevention in Canada. The company offers aerosol sprays, hand cleansers, hand creams, and nano bioguard; and disinfectant spray products. It also provides diagnostic testing, textile, PPE, and food solutions. Its products are used in medicine, textiles, chemicals, and additives industries to combat microorganisms. NAVCO Pharmaceuticals Inc. is headquartered in Vancouver, Canada.
Healthcare
Drug Manufacturers - Specialty & Generic
TSXV
Key Financial Metrics
-
Revenue
-93,680
Net Income
C$-0.04
EPS (Diluted)
-10,268
Free Cash Flow
Profitability
Gross Margin
-
Operating Margin
-
Net Profit Margin
-
EBITDA
-100,092
Returns & Efficiency
Return on Assets (ROA)
-83.5%
Return on Equity (ROE)
-2698.2%
Dividend Yield
-
Payout Ratio
-
Financial Health
Total Assets
112,171
Total Debt
-
Debt to Equity
-
Current Ratio
1.03
Company Info
| Industry | Drug Manufacturers - Specialty & Generic |
| HQ | Vancouver, Canada |
| Fiscal Year End | 1759190400 |
| Currency | CAD |
| Website | navcopharma.com |
Peers
Bausch + Lomb Corporation
BLCO.TO
7.9B
P/E: --
Bausch Health Companies Inc.
BHC.TO
2.5B
P/E: 12.0
Extendicare Inc.
EXE.TO
2.5B
P/E: 23.7
Sienna Senior Living Inc.
SIA.TO
2.2B
P/E: 53.2
Cronos Group Inc.
CRON.TO
1.4B
P/E: 24.1
Tilray Brands, Inc.
TLRY.TO
1.2B
P/E: --
WELL Health Technologies Corp.
WELL.TO
1.1B
P/E: --
Knight Therapeutics Inc.
GUD.TO
631.8M
P/E: --
Insider Activity
Sentiment
Bullish
Shares Bought
150,000
Shares Sold
0
Total Transactions
1
SEDAR+ Filings
View All Filings7
Annual Reports
21
Quarterly Reports
28
MD&A
17
News Releases
6
Material Changes
2
Prospectuses
12
Governance
61
Certifications
59
Other
●
2018-09-28
●
2018-08-13
Interactive Charts
Company Profile
General Information
| Company Name | NAVCO Pharmaceuticals Inc. |
| Ticker | NAV.V |
| Exchange | TSXV |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Headquarters | Vancouver, Canada |
| Fiscal Year End | 1759190400 |
| Currency | CAD |
| Website | navcopharma.com |
Financial Summary
| Market Cap | 285,347 |
| Revenue | N/A |
| Net Income | -93,680 |
| P/E Ratio | N/A |
| EPS (Diluted) | C$-0.04 |
| Net Margin | N/A |
| ROE | -2698.2% |
| Dividend Yield | N/A |
Business Description
NAVCO Pharmaceuticals Inc. develops and commercializes supplemental and therapeutic consumer health and wellness products in the areas of antibacterial and immunity support and infectious disease prevention in Canada. The company offers aerosol sprays, hand cleansers, hand creams, and nano bioguard; and disinfectant spray products. It also provides diagnostic testing, textile, PPE, and food solutions. Its products are used in medicine, textiles, chemicals, and additives industries to combat microorganisms. NAVCO Pharmaceuticals Inc. is headquartered in Vancouver, Canada.